the role of chemoimmunotherapy in the era of targeted therapies for cll
Published 1 year ago • 92 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
3:51
the role of frontline chemoimmunotherapy in the era of novel agents in cll
-
2:23
the importance of genomic testing in cll in the era of novel therapies
-
1:00
the future of cll treatment: chemotherapy and targeted inhibitors
-
1:40
is the era of chemotherapy over in cll?
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
4:17
how to approach r/r cll
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
3:05
diagnosis and management of cmml
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:17
still a role for chemoimmunotherapy in cll: green results
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
1:29
the importance of treatment sequencing in cll
-
1:21
the role of transplant in the era of new treatments for lymphoma and cll
-
0:59
is chemoimmunotherapy in the relapsed/refractory setting still useful in cll?
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:18
involving the patient in treatment decisions for cll
-
2:00
associated toxicities of novel therapies for cll
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
1:37
the importance of genomic testing in the diagnosis of cll
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:15
exciting updates in cll and the importance of immune characterization